Can-Fite Biopharma Ltd CANF
2.16
(0.01)
(0.46%)
as of 25 Sep
- Market cap
- $6.5M
- P/E
- 0.0×
Follow CANF
| Older periods | Sep '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(140.94%) | 0.00% | 0.00% | 0.00% | |
| (81.58%) | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(129.29%) | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | (18.64) | (19.92) | (19.15) | |
Capital Expenditures |
— | (0.02) | (0.01) | (0.01) | |
| Other line items | |||||
Cash ROIC |
0.00% | (258.44%) | (187.13%) | (160.93%) | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
915.12% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
390.01% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.72 | 7.60 | 6.60 | |
Capex/Depreciation |
— | (0.83) | (0.32) | (0.24) | |
Revenue per Share |
0.17 | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(1,148.62%) | — | — | — |
Columns are period end dates